A recent scientific breakthrough could some day allow doctors to properly diagnose chronic traumatic encephalopathy (CTE) in the living, hopefully helping scores of football players and others avoid the degenerative brain disease caused by head trauma.

Scientists now believe a toxic protein tied to Alzheimer’s disease might be useful in identifying those with advanced CTE, which currently can only be diagnosed posthumously. For years, differentiating between CTE and other health issues linked to head trauma has been a major obstacle in treating at-risk patients.

Now two small studies are highlighting a new clue – that a blood test being developed to spot abnormal tau in the brains of Alzheimer’s patients seems to also detect buildup of that protein in people with advanced CTE.

‘This is a game changer,’ Michael Alosco, co-director of clinical research at the Boston University CTE Center and an author of the new study, said of the work. 

‘Today marks an important moment in the fight against CTE,’ agreed Chris Nowinski, founder of the Concussion & CTE Foundation. ‘For years, one of the greatest challenges in CTE research has been that the disease can only be definitively diagnosed after death. This new study, published in [peer-reviewed medical journal] JAMA and led by our research partners at

[Boston University CTE Center] and [Banner Health], brings us another step closer to changing that.

Giants quarterback Jaxson Dart (6) is helped off the field after being sacked by Minnesota Vikings’ Jay Ward in August. A spotter called for a concussion check, but Dart was cleared

Then-Giants receiver Golden Tate gets checked for a concussion during a 2019 game 

‘We know there is still a long road ahead,’ Nowinski, a PhD. who previously played college football, said in a social media video. ‘But every discovery brings us closer to a future with earlier detection, better opportunities for treatment, and ultimately, answers for the individuals and families affected by CTE. This is why we do this work. And we are not slowing down.’

Tau normally supports neurons but in Alzheimer’s, it tangles inside those nerve cells. Scientists are developing a blood test to track those tangles by detecting a particular tau fragment called eMTBR-tau243. But researchers at Washington University in St. Louis got a surprise when using autopsy records to study the new test – finding someone with high levels of that biomarker who didn’t have Alzheimer’s but CTE instead.

The researchers turned to a larger collection of autopsied brain and blood samples, eventually testing blood stored from 11 people classified as having CTE.

Compared to samples stored from healthy people, levels of eMTBR-tau243 were higher in those with advanced CTE, said study co-author Chihiro Sato, a WashU assistant neurology professor. That biomarker couldn’t reliably identify early-stage CTE, the research team reported at a dementia meeting in Japan last week.

Separately, researchers at Boston University and Arizona’s Banner Health were studying the same question using blood stored from 21 former professional or school football players who also donated their brain for research after death. Autopsies found 16 died with advanced CTE, two with earlier-stage CTE and three didn’t have the disease.

These brain scan images provided by Biogen show how high levels of Alzheimer’s-related tau protein, in red, dropped in a recipient of the company’s experimental drug diranersen

Blood levels of that tau biomarker were significantly higher in the athletes with advanced CTE, the researchers reported Thursday at a scientific meeting in Boston. Adding to the complexity, five of those with CTE also had Alzheimer’s disease, resulting in the highest levels of that tau biomarker.

Both studies were published in the medical journal JAMA.

The possible CTE link is interesting but very preliminary, requiring much larger studies to see if there’s a real connection, cautioned Northwestern University neuropathologist Dr Rudolph Castellani, who wasn’t involved with the research.

Abnormal tau is found in several additional brain diseases, which can overlap in older adults. Moreover, tau buildup in CTE is different from the type that occurs in Alzheimer’s, Drs. Günter Höglinger and Carla Palleis of Germany’s Ludwig Maximilian University of Munich wrote in an accompanying editorial in the journal.

They also stressed the need for far more research, while saying the two studies together ‘represent an important step’ in the quest to one day detect CTE in living patients.

That research is particularly important for the NFL, where the CTE rate has been the focus of widespread speculation. One October study found 75 percent of former NFL players who died between 2008 and 2023 had the neurodegenerative brain disease.

The study was published in JAMA Network Open by researchers at Boston University, Mass General Brigham and the Concussion & CTE Foundation. Some of those same researchers also published a paper in August that estimated one in four former NFL players who died between 2016 and 2021 had CTE.

Symptoms include memory loss, depression and suicidal thoughts but it can only be definitively diagnosed after death.

Julia Gallini, the lead author on the paper, said the estimated figure of 75 percent was ‘concerning.’ She insisted more needs to be done ‘to support families, diagnose CTE during life, and treat CTE-related symptoms.’

A new study has claimed 75 percent of ex-NFL players who died between 2008-2023 had CTE

Studies suggest that more than 300 deceased players have suffered from the debilitating condition associated with repeated blows to the head during contact sports like football and boxing.

The more than 300 players diagnosed posthumously include former Chicago Bears safety Dave Duerson, a four-time Pro Bowler, who shot himself in the chest in 2011 after writing a note asking for his brain to be examined.

Retired San Diego Chargers linebacker Junior Seau killed himself the following year. A study of his brain later revealed damage consistent with CTE.

The disorder was also discussed after Vontae Davis, the 35-year-old brother of Super Bowl winner Vernon Davis, was found dead at his Florida mansion in April 2024 after he binged on methamphetamine, MDMA and cannabis.

His ex-wife Megan Harpe told the Daily Mail: ‘The struggles Vontae endured during and after his NFL career – the confusion, mood changes, memory loss, impulsivity, changes in character, extreme changes in behavior – were real.

‘I never needed a CTE diagnosis to know what I was dealing with when Vontae retired. Those symptoms shaped the final year of his life, which ended too soon.’



Source link

Share.
Exit mobile version